Fred Hutchinson Cancer Research Center, home to three Nobel laureates, is an independent, nonprofit research institute based in Seattle. Its interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Its Vaccine and Infectious Disease Division, which is home to more than 70 faculty members, was established to facilitate and enhance the Hutch's efforts in infectious disease prevention and vaccine development.
The McElrath and Stamatatos laboratories, within the Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center, collaborate on the design, preclinical and clinical evaluation of novel immunogens against pathogens causing HIV, EBV, TB, HPV and malaria. We employ cutting-edge immunological and immunogen-design approaches, combined with next generation gene sequencing and bioinformatic tools, to interrogate in the greatest detail possible the interaction of candidate vaccines with the human immune system and to develop immunization schemas to guide the development of protective immune responses.
Our two laboratories are recruiting Research Technicians to participate in a join project aiming at the characterization of anti-HIV B cell responses elicited in adults and infants during infection and following immunization.
The successful candidates will work under the overall direction of the Principal Investigators, within a research team with diverse expertise. They will employ Molecular and Immunology-based approaches, analyze experimental data and summarize the results. They are expected to balance diverse responsibilities in a timely manner. Additionally, the candidates will perform general laboratory duties.